首页> 外文期刊>Neurotoxicology >Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line
【24h】

Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line

机译:磷脂酰肌醇3激酶(PI3K)调节鼠纹状体细胞系中锰稳态和锰诱导的细胞信号传导

获取原文
获取原文并翻译 | 示例
           

摘要

In a recent study, we found that blocking the protein kinase ataxia telangiectasia mutated (ATM) with the small molecule inhibitor (SMI) KU-55933 can completely abrogate Mn-induced phosphorylation of p53 at serine 15 (p-p53) in human induced pluripotent stem cell (hiPSC)-differentiated striatal neuro-progenitors. However, in the immortalized mouse striatal progenitor cell line STHdh(Q7/Q7), a concentration of KU55933 far exceeding its IC50 for ATM was required to inhibit Mn-induced p-p53. This suggested an alternative signaling system redundant with ATM kinase for activating p53 in this cell line-one that was altered by KU55933 at these higher concentrations (i.e. mTORC1, DNApk, PI3K). To test the hypothesis that one or more of these signaling pathways contributed to Mn-induced p-p53, we utilized a set of SMIs (e.g. NU7441 and LY294002) known to block DNApk, PI3K, and mTORC1 at distinct concentrations. We found that the SMIs inhibit Mn-induced p-p53 expression near the expected IC50, for PI3K, versus other known targets. We hypothesized that inhibiting PI3K reduces intracellular Mn and thereby decreases activation of p53 by Mn. Using the cellular fura-2 manganese extraction assay (CFMEA), we determined that KU55933/60019, NU7441, and LY294002 (at concentrations near their IC50, for PI3K) all decrease intracellular Mn (similar to 50%) after a dual, 24-h Mn and SMI exposure. Many pathways are activated by Mn aside from p-p53, including AKT and mTOR pathways. Thus, we explored the activation of these pathways by Mn in STHdh cells as well as the effects of other pathway inhibitors. p-AKT and p-S6 activation by Mn is almost completely blocked upon addition of NU7441(5 mu M) or LY294002(7 mu M), supporting PI3K's upstream role in the AKT/mTOR pathway. We also investigated whether PI3K inhibition blocks Mn uptake in other cell lines. LY294002 exposure did not reduce Mn uptake in ST14A, Neuro2A, HEK293, MEF, or hiPSC-derived neuroprogenitors. Next, we sought to determine whether inhibition of PI3K blocked p53 phosphorylation by directly blocking an unknown PI3K/p53 interaction or indirectly reducing intracellular Mn, decreasing p-p53 expression. In-Cell Western and CFMEA experiments using multiple concentrations of Mn exposures demonstrated that intracellular Mn levels directly correlated with p-p53 expression with or without addition of LY294002. Finally, we examined whether PI3K inhibition was able to block Mn-induced p-p53 activity in hiPSC-derived striatal neuroprogenitors. As expected, LY294002 does not block Mn-induced p-p53 as PI3K inhibition is unable to reduce Mn net uptake in this cell line, suggesting the effect of LY294002 on Mn uptake is relatively specific to the STHdh mouse striatal cell line. (C) 2017 Elsevier B.V. All rights reserved.
机译:在最近的一项研究中,我们发现阻断蛋白激酶与小分子抑制剂(SMI)Ku-55933突变(ATM)突变(ATM)可以在人诱导多能的丝氨酸15(P-P53)中完全消除MN诱导的P53磷酸化干细胞(HIPSC) - 化层状纹状体神经祖细胞。然而,在永生化小鼠纹状体祖细胞系STHDH(Q7 / Q7)中,需要远超过其IC50的Ku55933浓度,以抑制Mn诱导的P-P53。这提出了一种替代的信号传导系统,其具有ATM激酶,用于激活该细胞系中的P53-一种,其在这些较高浓度下由Ku55933改变(即MTORC1,DNAPK,PI3K)。为了测试假设,即这些信号传导途径中的一种或多种导致MN诱导的P-P53,我们已知已知为DNAPK,PI3K和MTORC1的一组SMIS(例如Nu741和Ly294002)以不同的浓度。我们发现SMIS抑制了PI3K的预期IC50附近的MN诱导的P-P53表达与其他已知靶标。我们假设抑制PI3K减少细胞内Mn,从而降低Mn的P53活化。使用细胞呋喃 - 2锰萃取测定(CFMEA),我们确定Ku55933 / 60019,Nu741和Ly294002(在其IC 50附近的浓度为PI3K)所有在双重,24-后均降低细胞内Mn(类似于50%) H Mn和SMI暴露。许多途径通过Mn激活,除了P-P53,包括AKT和MTOR途径。因此,我们探讨了Mn在STHDH细胞中的这些途径的激活以及其他途径抑制剂的影响。在添加Nu7441(5μm)或Ly294002(7μm)后,Mn的P-AKT和P-S6的激活几乎完全阻塞,支持PI3K在AKT / MTOR途径中的上游作用。我们还研究了PI3K抑制是否阻断MN在其他细胞系中的吸收。 LY294002暴露在ST14A,Neuro2A,HEK293,MEF或HIPSC衍生的神经尿激素中没有减少Mn吸收。接下来,我们试图通过直接阻断未知的PI3K / P53相互作用或间接降低细胞内MN,降低P-P53表达,确定是否抑制PI3K阻断P53磷酸化。使用多种Mn曝光的细胞内和CFMEA实验证明,细胞内MN水平与P-P53表达直接相关,或者不添加Ly294002。最后,我们检查了PI3K抑制是否能够阻断HIPSC衍生的纹状体神经抑制剂中的MN诱导的P-P53活性。正如预期的那样,LY294002不阻止MN诱导的P-P53,因为PI3K抑制不能降低该细胞系中的Mn净摄取,表明Ly294002对Mn吸收的影响相对特异于STHDH小鼠纹状体细胞系。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号